In addition, NK cell depletion was performed, since NK cells are also known to contribute to the therapeutic efficacy of both DC‐based cancer vaccines and VSV.27, 28 We depleted either CD8 T cells or NK cells alone or together during DCVacc/VSV‐GP treatments. Here, CD8A is linked to cancer.